Victoria is home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it a highly sought-after destination by global companies.
This growth story is supported by the Australian and Victorian Governments with a longstanding commitment to the industry.
The commercial sector includes more than 650 companies based in Victoria, including 69 ASX-listed companies with a combined market capitalisation of A$83 billion.
The combined sector employs more than 23,000 people and in 2014 generated A$12.7 billion in revenue, up from A$3.3 billion in 2002-03.
Melbourne has the highest number of Australian ASX-listed life science companies and many are partnering with multinational companies, such as Roche and Siemens Healthcare. Local organisations include fast growing innovator Starpharma, with its dendrimer delivery platform for medical and agricultural applications; and IDT Australia who specialise in the development, scale-up, and cGMP clinical and commercial manufacture of high potency and cytotoxic API and finished drug product.
People who read this were also interested in:
> A skilled and ethnically diverse participant recruitment pool
> Where do clinical trials take place?
> What are the attractive tax incentives and who is eligible?